| Year |
Citation |
Score |
| 2023 |
Miguel L, Gervais J, Nicolas G, Lecourtois M. SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants. Journal of Alzheimer's Disease : Jad. PMID 37424467 DOI: 10.3233/JAD-230211 |
0.422 |
|
| 2022 |
Miguel L, Rovelet-Lecrux A, Chambon P, Joly-Helas G, Rousseau S, Wallon D, Epelbaum S, Frébourg T, Campion D, Nicolas G, Lecourtois M. Generation of 17q21.31 duplication iPSC-derived neurons as a model for primary tauopathies. Stem Cell Research. 61: 102762. PMID 35358831 DOI: 10.1016/j.scr.2022.102762 |
0.738 |
|
| 2021 |
Rovelet-Lecrux A, Feuillette S, Miguel L, Schramm C, Pernet S, Quenez O, Ségalas-Milazzo I, Guilhaudis L, Rousseau S, Riou G, Frébourg T, Campion D, Nicolas G, Lecourtois M. Impaired SorLA maturation and trafficking as a new mechanism for SORL1 missense variants in Alzheimer disease. Acta Neuropathologica Communications. 9: 196. PMID 34922638 DOI: 10.1186/s40478-021-01294-4 |
0.67 |
|
| 2021 |
Wallon D, Boluda S, Rovelet-Lecrux A, Thierry M, Lagarde J, Miguel L, Lecourtois M, Bonnevalle A, Sarazin M, Bottlaender M, Mula M, Marty S, Nakamura N, Schramm C, Sellal F, et al. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers. Acta Neuropathologica. PMID 34095977 DOI: 10.1007/s00401-021-02320-4 |
0.679 |
|
| 2020 |
Miguel L, Frebourg T, Campion D, Lecourtois M. Moderate Overexpression of Tau in Drosophila Exacerbates Amyloid-β-Induced Neuronal Phenotypes and Correlates with Tau Oligomerization. Journal of Alzheimer's Disease : Jad. PMID 32065789 DOI: 10.3233/Jad-190906 |
0.653 |
|
| 2019 |
Miguel L, Rovelet-Lecrux A, Feyeux M, Frebourg T, Nassoy P, Campion D, Lecourtois M. Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons. Stem Cell Research. 40: 101541. PMID 31522011 DOI: 10.1016/J.Scr.2019.101541 |
0.714 |
|
| 2018 |
Pons M, Prieto S, Miguel L, Frebourg T, Campion D, Suñé C, Lecourtois M. Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila. Acta Neuropathologica Communications. 6: 138. PMID 30541625 DOI: 10.1186/S40478-018-0639-5 |
0.63 |
|
| 2018 |
Miguel L, Avequin T, Pons M, Frébourg T, Campion D, Lecourtois M. FTLD/ALS-linked TDP-43 mutations do not alter TDP-43's ability to self-regulate its expression in Drosophila. Brain Research. PMID 29778779 DOI: 10.1016/J.Brainres.2018.05.021 |
0.594 |
|
| 2017 |
Pons M, Miguel L, Miel C, Avequin T, Juge F, Frebourg T, Campion D, Lecourtois M. Splicing factors act as genetic modulators of TDP-43 production in a new autoregulatory TDP-43 Drosophila model. Human Molecular Genetics. 26: 3396-3408. PMID 28854702 DOI: 10.1093/Hmg/Ddx229 |
0.598 |
|
| 2017 |
Khalil B, Cabirol-Pol MJ, Miguel L, Whitworth AJ, Lecourtois M, Liévens JC. Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies. Neurobiology of Aging. 54: 71-83. PMID 28324764 DOI: 10.1016/J.Neurobiolaging.2017.02.016 |
0.476 |
|
| 2014 |
Salado IG, Redondo M, Bello ML, Perez C, Liachko NF, Kraemer BC, Miguel L, Lecourtois M, Gil C, Martinez A, Perez DI. Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. Journal of Medicinal Chemistry. 57: 2755-72. PMID 24592867 DOI: 10.1021/Jm500065F |
0.4 |
|
| 2012 |
Miguel L, Avequin T, Delarue M, Feuillette S, Frébourg T, Campion D, Lecourtois M. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiology of Aging. 33: 1008.e1-15. PMID 22118902 DOI: 10.1016/J.Neurobiolaging.2011.10.008 |
0.724 |
|
| 2011 |
Miguel L, Frébourg T, Campion D, Lecourtois M. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiology of Disease. 41: 398-406. PMID 20951205 DOI: 10.1016/J.Nbd.2010.10.007 |
0.685 |
|
| 2011 |
Miguel L, Frébourg T, Campion D, Lecourtois M. P3-030: Characterization in drosophila of TDP-43 physiopathological pathways Alzheimer's & Dementia. 7: S524-S524. DOI: 10.1016/J.Jalz.2011.05.1469 |
0.465 |
|
| 2010 |
Feuillette S, Miguel L, Frébourg T, Campion D, Lecourtois M. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. Journal of Neurochemistry. 113: 895-903. PMID 20193038 DOI: 10.1111/J.1471-4159.2010.06663.X |
0.722 |
|
| Show low-probability matches. |